Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

NCT01690520 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Biphenotypic Leukemia
Acute Lymphoblastic Leukemia in Remission
Acute Myeloid Leukemia in Remission
Chronic Myelogenous Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion
DRUG: Fludarabine Phosphate
DRUG: Mycophenolate Mofetil
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation

Sponsor

Nohla Therapeutics, Inc.

Collaborators

[object Object]
[object Object]